Department of Geriatric Medicine, Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, 975 N. E. 10th Street-BRC 1303, Oklahoma City, OK, 73104, USA.
Department of Biology and Wildlife, Center for Alaska Native Health Research, University of Alaska Fairbanks, 902 N. Koyukuk, Fairbanks, AK, 99775, USA.
Geroscience. 2017 Apr;39(2):147-160. doi: 10.1007/s11357-017-9966-x. Epub 2017 Feb 23.
Experimental, clinical, and epidemiological findings support the concept of developmental origins of health and disease (DOHAD), suggesting that early-life hormonal influences during a sensitive period around adolescence have a powerful impact on cancer morbidity later in life. The endocrine changes that occur during puberty are highly conserved across mammalian species and include dramatic increases in circulating GH and IGF-1 levels. Importantly, patients with developmental IGF-1 deficiency due to GH insensitivity (Laron syndrome) do not develop cancer during aging. Rodents with developmental GH/IGF-1 deficiency also exhibit significantly decreased cancer incidence at old age, marked resistance to chemically induced carcinogenesis, and cellular resistance to genotoxic stressors. Early-life treatment of GH/IGF-1-deficient mice and rats with GH reverses the cancer resistance phenotype; however, the underlying molecular mechanisms remain elusive. The present study was designed to test the hypothesis that developmental GH/IGF-1 status impacts cellular DNA repair mechanisms. To achieve that goal, we assessed repair of γ-irradiation-induced DNA damage (single-cell gel electrophoresis/comet assay) and basal and post-irradiation expression of DNA repair-related genes (qPCR) in primary fibroblasts derived from control rats, Lewis dwarf rats (a model of developmental GH/IGF-1 deficiency), and GH-replete dwarf rats (GH administered beginning at 5 weeks of age, for 30 days). We found that developmental GH/IGF-1 deficiency resulted in persisting increases in cellular DNA repair capacity and upregulation of several DNA repair-related genes (e.g., Gadd45a, Bbc3). Peripubertal GH treatment reversed the radiation resistance phenotype. Fibroblasts of GH/IGF-1-deficient Snell dwarf mice also exhibited improved DNA repair capacity, showing that the persisting influence of peripubertal GH/IGF-1 status is not species-dependent. Collectively, GH/IGF-1 levels during a critical period during early life determine cellular DNA repair capacity in rodents, presumably by transcriptional control of genes involved in DNA repair. Because lifestyle factors (e.g., nutrition and childhood obesity) cause huge variation in peripubertal GH/IGF-1 levels in children, further studies are warranted to determine their persisting influence on cellular cancer resistance pathways.
实验、临床和流行病学研究结果支持健康与疾病的发育起源(DOHAD)概念,表明青春期前后敏感时期的早期激素影响对晚年的癌症发病率有强大影响。青春期发生的内分泌变化在哺乳动物物种中高度保守,包括循环生长激素(GH)和胰岛素样生长因子-1(IGF-1)水平的显著增加。重要的是,由于 GH 不敏感导致 IGF-1 发育缺陷的患者(拉隆综合征)在衰老过程中不会发生癌症。GH/IGF-1 发育缺陷的啮齿动物在老年时也表现出明显降低的癌症发病率、对化学诱发性致癌作用的显著抗性以及细胞对遗传毒性应激源的抗性。用 GH 对 GH/IGF-1 缺陷的小鼠和大鼠进行早期治疗可逆转癌症抗性表型;然而,潜在的分子机制仍不清楚。本研究旨在检验这样一个假设,即发育中的 GH/IGF-1 状态影响细胞 DNA 修复机制。为了实现这一目标,我们评估了源自对照大鼠、Lewis 矮小症大鼠(GH/IGF-1 发育缺陷的模型)和 GH 充足的矮小症大鼠(从 5 周龄开始给予 GH,持续 30 天)的原代成纤维细胞中 γ 射线诱导的 DNA 损伤修复(单细胞凝胶电泳/彗星试验)和基础及辐射后与 DNA 修复相关的基因表达(qPCR)。我们发现,GH/IGF-1 发育缺陷导致细胞 DNA 修复能力持续增加和几种与 DNA 修复相关的基因上调(例如,Gadd45a、Bbc3)。青春期 GH 治疗逆转了辐射抗性表型。GH/IGF-1 缺陷的 Snell 矮小症小鼠的成纤维细胞也表现出改善的 DNA 修复能力,表明青春期 GH/IGF-1 状态的持续影响不是物种依赖性的。总之,生命早期关键时期的 GH/IGF-1 水平决定了啮齿动物的细胞 DNA 修复能力,推测是通过参与 DNA 修复的基因的转录控制。由于生活方式因素(例如营养和儿童肥胖)导致儿童青春期 GH/IGF-1 水平发生巨大变化,因此需要进一步研究以确定它们对细胞癌症抗性途径的持续影响。